[Pathophysiology of and therapy for hemophagocytic syndrome].
Kawa
Keisei
K
D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D015616:Histiocytosis, Non-Langerhans-Cell / Q000145:classification / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008264:Macrophages / Q000276:immunology; D010951:Plasma Exchange; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines; D005047:Etoposide; D016572:Cyclosporine; D011239:Prednisolone